ArticlePlastic and reconstructive surgery. Global open2026
Long-term Outcome After Correction of Lower Eyelid Retraction With Donor Sclera in Thyroid Eye Disease.
Article in Plastic and reconstructive surgery. Global open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Marker-Free, Automated Eyelid Assessment in Thyroid Eye Disease Using Artificial Intelligence: A Multicenter Validation Study.Ophthalmology science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Lower eyelid retraction is a common feature of thyroid eye disease (TED). Various spacer materials have been used for surgical correction, but long-term data on donor sclera are missing. Methods: A retrospective study of all TED patients treated with donor sclera to correct lower eyelid retraction was performed at the Department of Ophthalmology, Haukeland University Hospital, from 1999 to 2023. Data were obtained from hospital records and follow-up examinations. Outcomes were graded as perfect (scleral show of 0 mm), acceptable (0 mm < scleral show ≤ 1 mm), and unacceptable (scleral show >1 mm). Results: Thirty-five patients (29 women, 6 men) with a median age (range) of 57 (20-79) years and a median time from TED onset to surgery of 72 (12-468) months were included. At first follow-up, 3 (0.03-12) months postoperatively, scleral show improved significantly ( Conclusions: Correction of lower eyelid retraction with donor sclera in TED patients provides satisfactory short-term outcomes. However, over time, relapse of retraction commonly occurs.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.